ASSET PURCHASE AGREEMENT As of April 6, 2009Asset Purchase Agreement • April 7th, 2009 • EPIX Pharmaceuticals, Inc. • Pharmaceutical preparations • Massachusetts
This ASSET PURCHASE AGREEMENT (this “Agreement”) is made by and between EPIX Pharmaceuticals, Inc., a Delaware corporation (“Seller”), and Lantheus Medical Imaging, Inc., a Delaware corporation (“Buyer”), as of the date first written above (the “Execution Date”). Buyer and Seller also may be referred to herein each as a “Party” and collectively as the “Parties.”
TERMINATION AGREEMENTTermination Agreement • April 7th, 2009 • EPIX Pharmaceuticals, Inc. • Pharmaceutical preparations • New York
WHEREAS, BSP (previously acting under the name Schering AG) and EPIX entered into a Strategic Collaboration Agreement dated June 9, 2000 as amended on December 22, 2000 (hereinafter referred to as “the Collaboration Agreement”) for the development and commercialization of a blood pool magnetic contrast agent designated as MS-325 (hereinafter referred to as “the Compound”).
